Encyclopedia

  • Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study
  • Add time:07/18/2019         Source:sciencedirect.com

    Piperazine Sulfonamide analogs (1–19) have been synthesized, characterized by different spectroscopic techniques and evaluated for α-amylase Inhibition. Analogs 1–19 exhibited a varying degree of α-amylase inhibitory activity with IC50 values ranging in between 1.571 ± 0.05 to 3.98 ± 0.397 μM when compared with the standard acarbose (IC50 = 1.353 ± 0.232 μM). Compound 1, 2, 3 and 7 showed significant inhibitory effects with IC50 value 2.348 ± 0.444, 2.064 ± 0.04, 1.571 ± 0.05 and 2.118 ± 0.204 μM, respectively better than the rest of the series. Structure activity relationships were established. Molecular docking studies were performed to understand the binding interaction of the compounds.

    We also recommend Trading Suppliers and Manufacturers of 1-(2-BROMOPHENYL)PIPERAZINE (cas 1011-13-8). Pls Click Website Link as below: cas 1011-13-8 suppliers


    Prev:Inhibition of monoamine oxidase by two substrate-analogues, with different preferences for 5-hydroxytryptamine neurons
    Next: Synthesis and biological evaluation of estrone 3-O-ether derivatives containing the piperazine moiety)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View